Recently, it was shown that loss of HNF1A, a homeodomain transcriptional regulator that recruits KDM6A to genomic binding sites, can phenocopy KDM6A loss and produce a sarcomatoid tumor morphology in conjunction with Kras mutation in mouse pancreas[75]. This evidence concerns the gene KRAS and neoplasm.